Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis

Medical Decision Making

Volumn 18, Issue 2 SUPPL., 1998, Pages

  Stinnett, Aaron A ^a   Mullahy, John ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

Cost effectiveness; Net health benefits; Uncertainty

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HEALTH STATUS; REVIEW; STATISTICAL MODEL; STOCHASTIC MODEL; ATTENTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; HUMAN; THEORETICAL MODEL; UNCERTAINTY;

EID: 0031900689     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989x98018002s09     Document Type: Review

References (38)

1. Manski CF. Analog Estimation Models in Econometrics. London, U.K.: Chapman and Hall, 1988.
2. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
3. O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care. 1994;32:150-63.
4. Mullahy J, Manning WG. Statistical issues in cost-effectiveness analyses. In: Sloan F (ed). Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. Cambridge, U.K.: Cambridge University Press, 1995.
5. Wakker P, Klaassen MP. Confidence intervals for cost/effectiveness ratios, Health Econ. 1995;4:373-81.
6. Poirier DJ. Intermediate Statistics and Econometrics. Cambridge, MA: MIT Press, 1995.
7. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med. 1996;15:1447-58.
8. Kelly AE, Haddix AC, Scanlon KS, Helmick CG, Mulinare J. Cost-effectiveness of strategies to prevent neural tube defects. In: Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
9. Obenchain RL, Melfi CA, Croghan TW, Buesching DP. Bootstrap analyses of cost-effectiveness in antidepressant pharmacotherapy. PharmacoEconomics. 1997;11:464-72.
10. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London, U.K.: Chapman and Hall, 1993.
11. Davidson R, MacKinnon JG. Estimation and Inference in Econometrics. New York: Oxford University Press, 1993.
12. Mullahy J. What you don't know can't hurt you? Statistical issues in designing medical technology evaluation standards. Med Care. 1996;34:DS124-DS135.
13. Stinnett AA. Adjusting for bias in C/E ratio estimates. Health Econ. 1996;5:470-2.
14. Stinnett AA, Paltiel AD. Estimating CE ratios under secondorder uncertainty, the mean ratio versus the ratio of means. Med Decis Making. 1997;17:483-9.
15. Matchar DB, Ancukiewicz M, Lipscomb J, Parmagiani G, Samsa G. Accounting for uncertainty in cost-effectiveness analysis illustrated by the stroke prevention policy model (abstr). Med Decis Making. 1995;15:420.
16. Siegel C, Laska E, Meisner M: Statistical methods for costeffectiveness analyses. Controlled Clinical Trials. 1996;17: 387-406.
17. Mullahy J. Which cost-effectiveness ratio? Using cost and effectiveness data to value medical technologies. Unpublished manuscript, 1997.
18. Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ. 1993;12:459-67.
19. Cantor SB. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making. 1994;14:259-65.
20. Comparative Benefits Modeling Project. A framework for cost-utility analysis of government health care programs: a report to the Office of Disease Prevention and Health Promotion, Public Health Service, U.S. Department of Health and Human Services, in cooperation with the Foundation for Health Services Research. 1992.
21. van Hout BA, Malwenn JA, Gordon GS, Rutten FFH. Costs, effects, and C/E ratios alongside a clinical trial. Health Econ. 1994;3:309-19.
22. Siegel JE, Weinstein MC, Torrance GW. Reporting cost-effectiveness studies and results. In: Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
23. Hirshleifer J, Riley JG. The Analytics of Uncertainty and Information. Cambridge, U.K.: Cambridge University Press, 1992.
24. Levy H. Stochastic dominance. In: Eatwell J, Milgate M, Newman P (eds). The New Palgrave: Utility and Probability. New York: W.W. Norton & Company, 1990.
25. Bawa VS. Stochastic dominance: a research bibliography. Management Science. 1982;28:698-712.
26. Kroll Y, Levy H. Stochastic dominance: a review and some new evidence. Research in Finance. 1980;2:163-227.
27. Rothschild M, Stiglitz JE. Increasing risk. I: A definition. Journal of Economic Theory. 1970;2:225-43.
28. Rothschild M, Stiglitz JE. Increasing risk. II: Its economic consequences. Journal of Economic Theory. 1971;3:66-84.
29. Willan AR, O'Brien BJ. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Econ. 1996;5:297-305.
30. Fioller EC. Some problems in interval estimation. Journal of the Royal Statistical Society, Series B. 1954;16:175-83.
31. Weinstein MC. From cost-effectiveness ratios to resource allocation: where to draw the line? In: Sloan FA (ed). Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. New York: Cambridge University Press, 1995.
32. Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of health care resources. J Health Econ. 1996;15:641-53.
33. Paltiel AD, Stinnett AA. Making health policy decisions: is human instinct rational? Is rational choice human? Chance. 1996;9(2):34-9.
34. Phelps CE, Mushlin AI. On the (near) equivalence of costeffectiveness and cost-benefit analyses. Int J Technol Assess Health Care. 1991;7:12-21.
35. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16:1-31.
36. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997;16:33-64.
37. Mishan EJ. Cost-Benefit Analysis. New York: Praeger, 1976.
38. Pauly MV. Valuing health care benefits in monetary terms. In: Sloan FA (ed). Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. New York: Cambridge University Press, 1995.